Literature DB >> 11823357

Improvement in cholesterol emboli syndrome after iloprost therapy.

Eran Elinav1, Tova Chajek-Shaul, Mirella Stern.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11823357      PMCID： PMC65057          DOI： 10.1136/bmj.324.7332.268

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  3 in total

Review 1.  Blue toe syndrome. Causes and management.

Authors:  S T O'Keeffe; B O Woods; D J Breslin; N P Tsapatsaris
Journal:  Arch Intern Med       Date:  1992-11

2.  After the blue toe: prognosis of noncardiac arterial embolization in the lower extremities.

Authors:  K H Kvilekval; J P Yunis; R A Mason; F Giron
Journal:  J Vasc Surg       Date:  1993-02       Impact factor: 4.268

Review 3.  Iloprost. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in peripheral vascular disease, myocardial ischaemia and extracorporeal circulation procedures.

Authors:  S M Grant; K L Goa
Journal:  Drugs       Date:  1992-06       Impact factor: 9.546
  3 in total
  7 in total

1.  Commentary: Iloprost for cholesterol emboli syndrome.

Authors:  Charles D Pusey
Journal:  BMJ       Date:  2002-03-09

2.  Blue toes.

Authors:  Mamatha Rao; Mahmood Al-Jufaili; Prashanth Panduranga; Abdullah Amour Riyami
Journal:  Oman Med J       Date:  2012-05

3.  Comparison of hyperbaric oxygen versus iloprost treatment in an experimental rat central retinal artery occlusion model.

Authors:  Suleyman Karaman; Berna Ozkan; Yusufhan Yazir; Melda Yardimoglu; Mustafa Gok; Ozgur Kara; Cigdem Vural; Selenay Rencber; Salih K Emek
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-08-02       Impact factor: 3.117

4.  Cholesterol crystal embolization mimicking vasculitis: success with corticosteroid and cyclophosphamide therapy in two cases.

Authors:  A E Yücel; H Kart-Köseoglu; B Demirhan; F N Ozdemir
Journal:  Rheumatol Int       Date:  2005-07-16       Impact factor: 2.631

5.  Cholestrol emboli syndrome: acute renal insufficiency after a procedure or a thrombolytic therapy or anticoagulant therapy.

Authors:  C Chandra Sekhar; Parveen Jindal; V Guru Karna; Manoj Aggarwala; Soma Sekhar
Journal:  Indian J Surg       Date:  2012-10-07       Impact factor: 0.656

6.  Treatment of Cholesterol Embolization Syndrome in the Setting of an Acute Indication for Anticoagulation Therapy.

Authors:  Hidong Kim; David B Zhen; John C Lieske; Robert D McBane; Joseph P Grande; Gurpreet S Sandhu; Rowlens M Melduni
Journal:  J Med Cases       Date:  2014-06-01

Review 7.  Risks and complications of coronary angiography: a comprehensive review.

Authors:  Morteza Tavakol; Salman Ashraf; Sorin J Brener
Journal:  Glob J Health Sci       Date:  2012-01-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.